Reply

Ophthalmology. 2016 Feb;123(2):e16. doi: 10.1016/j.ophtha.2015.08.034.

Authors

Ragnheiður Bragadóttir¹, Karina Berg², Terje R Pedersen²

Affiliations

¹ Department of Ophthalmology, Oslo University Hospital, Oslo, Norway. Electronic address: ragnheib@medisin.uio.no.
² Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.

PMID: 26802718
DOI: 10.1016/j.ophtha.2015.08.034

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Female
Humans
Male
Wet Macular Degeneration / drug therapy*

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized